Federation Des Caisses Desjardins Du Quebec Infinity Pharmaceuticals, Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $18.9 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2017

Aug 30, 2024
SELL
$0.94 - $1.35 $16,387 - $23,534
-17,433 Closed
0 $0
Q1 2017

Aug 30, 2024
BUY
N/A
17,433
17,433 $56.3 Million

Others Institutions Holding INFI

# of Institutions
3
Shares Held
1.26M
Call Options Held
0
Put Options Held
0
View Full List

About INFINITY PHARMACEUTICALS, INC.

INFI Quotes by TradingView
  • Ticker INFI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 89,277,904
  • Description
  • Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...
More about INFI
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email